Shares of eHealth (NASDAQ: EHTH) surged by more than 15% in pre-market trading after the private online health insurance marketplace announced preliminary Q4 and FY22 results.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
In FY22, the company expects to report revenues in the range of $395 to $405 million, better than its prior guidance of $375 to $395 million. In Q4, EHTH anticipates revenues to be between $190 million and $200 million.
Net loss for FY22 is also projected to be between $93 million and $88 million versus the company’s earlier guidance in the range of $115 million to $92 million.
More importantly, EHTH “exceeded its cost reduction goals for the full year 2022 by delivering over $110 million in net operating cost savings compared to the full year 2021.”
Analysts are sidelined about EHTH stock with a Hold consensus rating based on one Buy and four Holds.
Join our Webinar to learn how TipRanks promotes Wall Street transparency
